University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > SFGH PHP Grand Rounds > Peters > Slides
Managing the Changing Faces of HBV Infection in HIV
Slide 1.
Managing the changing faces of HBV infection in HIV
Slide 1.
Download slide
HIV Coinfection Increases the Risk of ESLD Due to HBV
Slide 2.
Download slide
Managing the changing faces of HBV infection in HIV
Slide 3.
Download slide
Managing the changing faces of HBV infection in HIV
Slide 4.
Download slide
Outcome of HBV by Age of Acquisition- immune status
Slide 5.
Download slide
Geographic Distribution of Chronic HBV Infection
Slide 6.
Download slide
Risk Factors for Acute Hepatitis B 1990-2000, United States
Slide 7.
Download slide
Overlapping HBV & HIV Epidemics
Slide 8.
Download slide
HBV Epidemiology
Slide 9.
Download slide
Hepatitis B Disease Progression
Slide 10.
Download slide
Natural History of Chronic HBV Infection
Slide 11.
Download slide
Managing the changing faces of HBV infection in HIV
Slide 12.
Download slide
HBV
Slide 13.
Download slide
HBeAg and precore mutation
Slide 14.
Download slide
HBeAg and precore mutation
Slide 15.
Download slide
Hepatitis B Serologies
Slide 16.
Download slide
Managing the changing faces of HBV infection in HIV
Slide 17.
Download slide
Initial evaluation of a person with newly identified HBV in HIV infection
Slide 18.
Download slide
HBV is a dynamic disease
Slide 19.
Download slide
HBV vaccine response rate
Slide 20.
Download slide
Managing the changing faces of HBV infection in HIV
Slide 21.
Download slide
Hepatitis B Serologies
Slide 22.
Download slide
Anti-HBcAg Alone: HBsAg-, HBsAb-
Slide 23.
Download slide
HBV- HIV Co-infection
Slide 24.
Download slide
Occult infection
Slide 25.
Download slide
Managing the changing faces of HBV infection in HIV
Slide 26.
Download slide
Viral Life Cycle
Slide 27.
Download slide
Viral Life Cycle- latent HBV
Slide 28.
Download slide
Clinical Treatment Endpoints in Compensated CHB
Slide 29.
Download slide
HBV Control
Slide 30.
Download slide
? Therapy in acute HBV
Slide 31.
Download slide
HBV- HIV therapy
Slide 32.
Download slide
HBV and HIV results with ADV
Slide 33.
Download slide
HBV- HIV therapy
Slide 34.
Download slide
HBV and HIV therapies
Slide 35.
Download slide
HBV treatment decision algorithm
Slide 36.
Download slide
Preferred anti-HBV agents in drug-naive HBV/HIV coinfected patients candidates for HBV therapy
Slide 37.
Download slide
HIV / HBV treatment
Slide 38.
Download slide
Monitoring HBV
Slide 39.
Download slide
Managing the changing faces of HBV infection in HIV
Slide 40.
Download slide
GLOBE: Early HBV DNA Levels and Year 1 Outcomes With Telbivudine
Slide 41.
Download slide
Monitor on therapy
Slide 42.
Download slide
Managing the changing faces of HBV infection in HIV
Slide 43.
Download slide
Chronic HBV HIV
Slide 44.
Download slide
Liver Disease in HIV Infection
Slide 45.
Download slide
HBV HIV and HAART: abnormal LFTs
Slide 46.
Download slide
Managing the changing faces of HBV infection in HIV
Slide 47.
Download slide
Resistance Rates in Naive Patients Treated with LMV, ADV or LdT
Slide 48.
Download slide
Month 6 HBV DNA Suppression Predicts Risk of Subsequent Lamivudine Resistance
Slide 49.
Download slide
Week 48 HBV DNA Suppression Predicts Risk of Subsequent Adefovir Resistance
Slide 50.
Download slide
HBV HIV resistance
Slide 51.
Download slide
Impact on natural history of each
Slide 52.
Download slide
Impact on natural history of each
Slide 53.
Download slide
HBV-HIV Summary
Slide 54.
Download slide